LONDON, UK AND PLANO, TX, August 2, 2019. Belluscura PLC announces the successful close of its latest fundraising round. Raising $2.7m, the private placing was priced at US$0.185 (15p) per share, giving Belluscura a post-money valuation of approximately US$9.0m. Beginning with an over-subscribed UK crowdfunding campaign on CrowdCube earlier this year, 12 existing shareholders and 325 new shareholders invested in … Read More
LONDON, UK AND PLANO, TX April 23, 2019. Belluscura PLC is excited to announce that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (https://www.crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company. This raise will enable Belluscura to continue moving forward with regulatory … Read More
A substantial new investment has brought our Crowdcube crowdfunding effort to 91% of our funding goal! We are thrilled and humbled to be supported by all the people who, like us, want to improve the lives of millions suffering from chronic lung diseases.
The Global Group UK Investor Show is UK’s number 1 investor event, owned by the Wray family. This year’s show took place March 30, featuring 125+ exhibitors and attracting 2,500 attendees. Investors that visited the Belluscura booth had the opportunity to meet the company CEO Bob Rauker and CFO Tony Dyer and learn more about the X-PLO2R portable oxygen concentrator. … Read More
Read full article: BELLUSCURA READIES TO LAUNCH X-PLO2R PLANO, Texas – Belluscura, a U.K. company that licenses and develops proprietary healthcare technologies, plans to launch a portable oxygen concentrator named the X-PLO2R in the U.S. market in the back half of this year. In March, Belluscura, which is headquartered in Plano, Texas, was in the middle of trying to raise … Read More
LONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of ARDS include sepsis, inhalation of … Read More
Visit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or any other country where it … Read More
To date, we have brought on more than 100 investors from 12 countries and we are very thankful for all the interest in, and support of the X-PLOR. Our goal is to help patients suffering from chronic lung diseases, such as COPD, to enjoy more active and fulfilling lifestyles. Please join us in helping millions of people in the world … Read More
Belluscura will be demonstrating the X-PLOR at the UK Investor Show on March 30. Come see us at Booth 65 for a hands-on experience with the world’s first modular portable oxygen concentrator.
We are getting numerous inquiries about the X-PLO2R being presented at the UK Investor Show. Having received so much interest, we decided to extend our crowdfunding campaign until April 5. Come see us at the show March 30 and don’t miss out on this unique investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada … Read More